Erasca insider plans sale of 80,000 shares
Erasca, Inc. filed a Form 144 reporting a proposed sale of 80,000 shares of Common Stock associated with a stock option, planned for 04/01/2026 and to be settled for cash.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. filed a Form 144 reporting a proposed sale of 80,000 shares of Common Stock associated with a stock option, planned for 04/01/2026 and to be settled for cash. The filing shows an aggregate value of $1,312,354.68 and lists 310,799,547 shares outstanding as of 04/01/2026 as a context figure. The filer also reported a prior sale of 120,000 shares on 01/07/2026 for $670,809.15.
Insights
Form 144 flags a planned insider sale of 80,000 shares via option exercise.
The notice indicates the transaction method as a stock option with cash settlement on 04/01/2026. Form 144 is a regulatory notice of an intended sale under Rule 144 and does not itself execute the sale.
Prior activity includes a reported sale of 120,000 shares on 01/07/2026 for $670,809.15; subsequent SEC filings will show whether the planned sale was completed.
Key Figures
Key Terms
Form 144 regulatory
Stock Option financial
Aggregate value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ERAS disclose in the Form 144?
Who is the filer and what prior sale is shown in the ERAS filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.